全球薄膜製藥生產市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計薄膜製劑製造市場將從 2025 年的 82.9 億美元成長到 2034 年的 184.4 億美元，2026 年至 2034 年的複合年成長率為 9.28%。

由於對創新藥物遞送系統的需求不斷成長，全球薄膜製劑市場正蓬勃發展。薄膜製劑設計成可溶性貼片，可透過口服或舌下吸收快速遞送藥物。這些薄膜具有許多優勢，包括起效更快、患者用藥依從性更高以及無需用水即可輕鬆給藥。

製藥公司正在加速開發用於治療疼痛、神經系統疾病、呼吸系統疾病和其他疾病的薄膜製劑。這些製劑尤其有利於吞嚥傳統藥片有困難的兒童和老年患者。薄膜形成技術和生產製程的進步正在提高薄膜製劑的穩定性和療效。

隨著製藥業持續創新，致力於研發更方便的給藥方式，市場預計將會成長。研發投入的增加將催生出適用於多種治療用途的新型薄膜製劑。隨著醫療機構日益重視用藥的便利性和病患的治療依從性，薄膜給藥技術也將得到更廣泛的應用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球薄膜製藥生產市場：依產品類別分類

• 市場分析、洞察與預測
• 口腔內膜（舌下膜，完全可溶解的牙科/頰黏膜膜）
• 經皮吸收薄膜
• 其他（例如眼科薄膜）

第5章：全球薄膜製藥生產市場：依適應症分類

• 市場分析、洞察與預測
• 思覺失調症
• 偏頭痛
• 鴉片類成癮
• 噁心和嘔吐
• 其他

第6章：全球薄膜製藥生產市場：依分銷管道分類

• 市場分析、洞察與預測
• 醫院藥房
• 藥局
• 零售藥房
• 電子商務

第7章 全球薄膜製藥生產市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Pfizer Inc
  • Novartis AG
  • Wolters Kluwer
  • Solvay
  • AbbVie
  • Sumitomo Pharma Co. Ltd
  • IntelGenx Corp
  • NAL Pharma
  • ZIM Laboratories Limited
  • Indivior PLC
  • MonoSol

The Thin Film Drug Manufacturing Market size is expected to reach USD 18.44 Billion in 2034 from USD 8.29 Billion (2025) growing at a CAGR of 9.28% during 2026-2034.

The global thin film drug manufacturing market is gaining momentum due to the growing demand for innovative drug delivery systems. Thin film drug formulations are designed as dissolvable strips that deliver medications quickly through oral or sublingual absorption. These films provide several advantages, including faster onset of action, improved patient compliance, and ease of administration without the need for water.

Pharmaceutical companies are increasingly developing thin film drug products for conditions such as pain management, neurological disorders, and respiratory diseases. These formulations are particularly beneficial for pediatric and geriatric patients who may have difficulty swallowing traditional tablets. Advances in film-forming technologies and manufacturing processes are improving the stability and effectiveness of thin film medications.

In the future, the market is expected to grow as pharmaceutical innovation continues to focus on patient-friendly drug delivery methods. Increasing investments in research and development will lead to the introduction of new thin film formulations for a wide range of therapeutic applications. As healthcare providers emphasize convenience and treatment adherence, thin film drug technologies will gain wider adoption.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film)
• Transdermal Thin Film
• Others (Ocular Thin Film, etc.)

By Disease Indication

• Schizophrenia
• Migraine
• Opioid Dependence
• Nausea & Vomiting
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• E-commerce

COMPANIES PROFILED

• Pfizer Inc, Novartis AG, Wolters Kluwer, Solvay, AbbVie, Sumitomo Pharma Co Ltd, IntelGenx Corp, NAL Pharma, ZIM Laboratories Limited, Indivior PLC, MonoSol
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL THIN FILM DRUG MANUFACTURING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transdermal Thin Film Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others (Ocular Thin Film, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THIN FILM DRUG MANUFACTURING MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Indication
• 5.2. Schizophrenia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Migraine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Opioid Dependence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nausea & Vomiting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THIN FILM DRUG MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. E-commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL THIN FILM DRUG MANUFACTURING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Disease Indication
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Disease Indication
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Disease Indication
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Disease Indication
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Disease Indication
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL THIN FILM DRUG MANUFACTURING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Pfizer Inc
  • 9.2.2 Novartis AG
  • 9.2.3 Wolters Kluwer
  • 9.2.4 Solvay
  • 9.2.5 AbbVie
  • 9.2.6 Sumitomo Pharma Co. Ltd
  • 9.2.7 IntelGenx Corp
  • 9.2.8 NAL Pharma
  • 9.2.9 ZIM Laboratories Limited
  • 9.2.10 Indivior PLC
  • 9.2.11 MonoSol